The African Development Bank is providing $15 million to Biovac in South Africa, boosting vaccine manufacturing capacity to 500 million doses annually and creating 340 jobs. Concurrently, the South African Health Products Regulatory Authority is reviewing twelve applications for generic semaglutide.
HPC Consultancy supports businesses in capitalizing on the growing health sector. We offer comprehensive market entry strategies for new medical innovations, assist in navigating regulatory landscapes for pharmaceutical products, and provide advisory services for expanding healthcare facilities or medical tourism initiatives.
